Overview
Bdparib Tablets contain Rucaparib, a targeted cancer therapy classified as a PARP (poly ADP-ribose polymerase) inhibitor. It is primarily used to treat ovarian and certain other types of cancers, especially in patients with BRCA gene mutations. Rucaparib works by blocking PARP enzymes, which help cancer cells repair damaged DNA, thereby promoting cancer cell death.





